Decitabine and Cedazuridine (DEC-C)
- Myelodysplastic Syndromes (MDS) /Chronic Myelomonocytic Leukemia (CMML):
- Novel combinations in high risk MDS/CMML with compelling biologic rationale
- Acute Myeloid Leukemia:
- Transplant
- Novel combination strategies for special subgroups
- Solid tumors: novel combinations with compelling biologic rationale